Role of the Stress in the Development of the Metabolic Syndrome
NCT ID: NCT01538082
Last Updated: 2012-02-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
738 participants
OBSERVATIONAL
2008-12-31
2013-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Our hypothesis is that population of the cohort with bigger degree of stress will develop earlier the metabolic syndrome.
If our hypothesis about the metabolic syndrome are demonstrated, it would allow establishing in a future interventions on these factors of risk to prevent or to decrease the incidence of this syndrome in the Primary Care.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Epidemiology of Stress and the Metabolic Syndrome
NCT00073775
Metabolic Syndrome and Related Diseases in Healthcare Workers
NCT06543706
Effect of MetS* on Cognitive Performance and Physical Activity (Metabolic Syndrome)
NCT05702437
Metabolic Syndrome of Occupational Drivers
NCT00982761
Relationship of Metabolic Syndrome and Its Components With Thyroid Nodule(s)
NCT03009279
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients without stress
Patients without any of the next items: Zung's questionnaire score over 19 points; SF-12 questionnaire score over 5 points; Stressful vital events score over 150 points.
No interventions assigned to this group
Patients with stress
Patients with stress, including: Zung's questionnaire punctuation over 19 points; SF-12 questionnaire score over 5 points; stressful vital events score over 150 points. All combinations are considered positive in stress.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Subjects with 1 or 2 criteria of NCEP-ATPIII set for Metabolic Syndrome
* Abdominal waist \> 102 cm ( men ) or \>88 cm ( women )
* Blood Pressure ( \>130/85 mmHg ) ( or else pharmacologic treatment of hypertension )
* Hypertriglyceridaemia ( \>150 mg/dl ) ( or else pharmacologic treatment )
* HDL-cholesterol \<40 mg/dl ( men ) or \<50 mg/dl ( women ) ( or else treatment )
* Fasting glucose \> 110 mg/dl.
Exclusion Criteria
* Severe or terminal disease
* Severe mental disease that difficulties the follow-up
40 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Catalan Society of Family Medicine
OTHER
Spanish Society of Family and Community Medicine
OTHER
Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Yolanda Ortega, MD
Role: PRINCIPAL_INVESTIGATOR
Catalan Institute of Health
Juan J Cabré, MD, PhD
Role: STUDY_DIRECTOR
Catalan Institute of Health
Josep L Piñol, MD, PhD
Role: STUDY_CHAIR
Catalan Institute of Health
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Catalan Health Institute. ABS Reus-4
Reus, Tarragona, Spain
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
7Z08/002
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.